Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
Hirotoshi WatanabeMasahiro NatsuakiTakeshi MorimotoKo YamamotoYuki ObayashiRyusuke NishikawaTomoya KimuraKenji AndoTakenori DomeiSatoru SuwaManabu OgitaTsuyoshi IsawaHiroyuki TakenakaTakashi YamamotoTetsuya IshikawaItaru HisauchiKohei WakabayashiYuko OnishiKiyoshi HibiKazuya KawaiRuka YoshidaHiroshi SuzukiGaku NakazawaTakanori KusuyamaItsuro MorishimaKoh OnoTakeshi KimuraPublished in: European heart journal (2024)
Aspirin monotherapy compared to clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up to 1 year after PCI with DES.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- combination therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- open label
- coronary artery disease
- coronary artery bypass grafting
- atrial fibrillation
- low dose
- cardiovascular events
- phase iii
- study protocol
- type diabetes
- cardiovascular disease
- randomized controlled trial
- skeletal muscle